Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - MusclePharm Corp | v426228_ex32-1.htm |
| EX-10.4 - EXHIBIT 10.4 - MusclePharm Corp | v426228_ex10-4.htm |
| EX-31.2 - EXHIBIT 31.2 - MusclePharm Corp | v426228_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - MusclePharm Corp | v426228_ex31-1.htm |
| 10-Q/A - 10-Q/A - MusclePharm Corp | v426228_10qa.htm |
Exhibit 32.2
Section 1350 CERTIFICATION
In connection with this Quarterly Report of MusclePharm Corporation (the “Company”), on Form 10-Q for the quarter ended March 31, 2015, as filed with the U.S. Securities and Exchange Commission on the date hereof (the “Report”), I, John Price, Principal Financial Officer of the Company, certify pursuant to 18 U.S.C. Section. 1350, as adopted pursuant to Section. 906 of the Sarbanes-Oxley Act of 2002, that:
| (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
| (2) | The information contained in the Report, fairly presents, in all material respects, the financial condition and results of operations of the Company. |
| Date: December 4, 2015 | By: | /s/ John Price |
| John Price | ||
| Principal Financial Officer |